| human | Q5 |
| P496 | ORCID iD | 0000-0002-3163-7202 |
| P735 | given name | Robert | Q4927937 |
| Robert | Q4927937 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q50092201 | A Macrophage Colony-Stimulating Factor-Producing γδ T Cell Subset Prevents Malarial Parasitemic Recurrence |
| Q44164288 | A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines |
| Q95336413 | A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1 |
| Q34753532 | A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites |
| Q30044020 | A novel multiple-stage antimalarial agent that inhibits protein synthesis |
| Q35887438 | A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses |
| Q35138735 | A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum |
| Q35048518 | A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice |
| Q50318730 | A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection model |
| Q39257146 | A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria |
| Q27973519 | A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites |
| Q39492523 | A scalable assessment of Plasmodium falciparum transmission in the standard membrane-feeding assay, using transgenic parasites expressing green fluorescent protein-luciferase |
| Q35873837 | A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes |
| Q58707703 | A sporozoite-based vaccination platform against human malaria |
| Q36057631 | A switch in infected erythrocyte deformability at the maturation and blood circulation of Plasmodium falciparum transmission stages |
| Q33308737 | A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial |
| Q43932772 | Age-dependent distribution of Plasmodium falciparum gametocytes quantified by Pfs25 real-time QT-NASBA in a cross-sectional study in Burkina Faso |
| Q37243605 | An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines |
| Q95336401 | An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria |
| Q35683366 | Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate--Tackling the Cocktail Challenge |
| Q47915916 | Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry |
| Q41500270 | Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model |
| Q34103586 | Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers |
| Q44156482 | Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity |
| Q94670449 | Antigen-stimulated PBMC transcriptional protective signatures for malaria immunization |
| Q39337756 | Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. |
| Q90167721 | Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in Plasmodium falciparum |
| Q44018391 | Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates |
| Q38935681 | Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies |
| Q40404046 | Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection |
| Q34233691 | Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity |
| Q33640267 | BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection |
| Q35914430 | Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice |
| Q35211003 | Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization |
| Q36004060 | Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection |
| Q112718334 | CRISPR/Cas9-engineered inducible gametocyte producer lines as a valuable tool for Plasmodium falciparum malaria transmission research |
| Q44169768 | Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers |
| Q28554466 | Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling |
| Q40281431 | Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites |
| Q43942938 | Common genotypic polymorphisms in glutathione S-transferases in mild and severe falciparum malaria in Tanzanian children |
| Q42682357 | Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens |
| Q28728616 | Comparison of clinical and parasitological data from controlled human malaria infection trials |
| Q47831976 | Complement activation in experimental human malaria infection |
| Q40105545 | Concentration of Plasmodium falciparum gametocytes in whole blood samples by magnetic cell sorting enhances parasite infection rates in mosquito feeding assays |
| Q24814551 | Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana |
| Q33750638 | Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine |
| Q56362793 | Controlled Human Malaria Infection with Graded Numbers of NF135.C10- or NF166.C8-Infected Mosquitoes |
| Q34138437 | Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites |
| Q40752958 | Controlled human malaria infection trials: How tandems of trust and control construct scientific knowledge |
| Q36523062 | Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites |
| Q46787789 | Controlled human malaria infections using aseptic, purified cryopreserved Plasmodium falciparum sporozoites administered by needle and syringe |
| Q36670217 | Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice |
| Q51711730 | Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesis. |
| Q36483682 | Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one? |
| Q38953222 | Cross-stage immunity for malaria vaccine development |
| Q34399831 | Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites |
| Q37154138 | Diagnosis and treatment based on quantitative PCR after controlled human malaria infection |
| Q35784129 | Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine-pyrimethamine treatment outcomes in Indonesia |
| Q37239022 | Dynamic histone H3 epigenome marking during the intraerythrocytic cycle of Plasmodium falciparum |
| Q46151189 | Early interferon-gamma response against Plasmodium falciparum correlates with interethnic differences in susceptibility to parasitemia between sympatric Fulani and Dogon in Mali |
| Q44149683 | Editorial: Malaria investments and activities: it is now! or never? |
| Q39331198 | Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial |
| Q33455349 | Efficacy of artemisinin-based combination therapy for treatment of persons with uncomplicated Plasmodium falciparum malaria in West Sumba District, East Nusa Tenggara Province, Indonesia, and genotypic profiles of the parasite |
| Q44164122 | Efficacy of preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers |
| Q37740562 | Empowering malaria vaccination by drug administration |
| Q37979164 | Enhancement of naturally acquired immunity against malaria by drug use. |
| Q42378882 | Erratum to: Diagnosis and treatment based on quantitative PCR after controlled human malaria infection |
| Q33933486 | Expansion of IgG+ B-cells during mitogen stimulation for memory B-cell ELISpot analysis is influenced by size and composition of the B-cell pool |
| Q44156054 | Experimental human challenge infections can accelerate clinical malaria vaccine development |
| Q40259296 | Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species |
| Q40159945 | Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite |
| Q56829633 | Extended malaria parasite clearance time in African children following artemisinin-combination therapy enhances transmission to Anopheles mosquitoes |
| Q28538917 | External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance |
| Q90665758 | Fast and fierce versus slow and smooth: Heterogeneity in immune responses to Plasmodium in the controlled human malaria infection model |
| Q38927122 | Gametocytemia and Attractiveness of Plasmodium falciparum-Infected Kenyan Children to Anopheles gambiae Mosquitoes |
| Q33380159 | Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes |
| Q47837113 | Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. |
| Q33922779 | Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells |
| Q48034345 | Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial |
| Q40448134 | HGF/MET signalling protects Plasmodium-infected host cells from apoptosis. |
| Q35560599 | Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites |
| Q34149880 | Hitting hotspots: spatial targeting of malaria for control and elimination |
| Q38096725 | How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection |
| Q52715900 | Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children. |
| Q47099112 | Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice |
| Q33934212 | Identification of a major rif transcript common to gametocytes and sporozoites of Plasmodium falciparum |
| Q37539836 | Idiopathic acute myocarditis during treatment for controlled human malaria infection: a case report |
| Q38728601 | Immune activation and induction of memory: lessons learned from controlled human malaria infection with Plasmodium falciparum |
| Q35509020 | Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver |
| Q35439859 | Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection |
| Q33826283 | In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals |
| Q38714971 | Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers. |
| Q47874621 | Influenza virosomes: a flu jab for malaria? |
| Q28742222 | Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations |
| Q37623775 | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes: molecular insight into sex-specific processes and translational repression |
| Q37770828 | Interferon-γ--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria |
| Q34057433 | KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission |
| Q58714876 | Liver Injury in Uncomplicated Malaria is an Overlooked Phenomenon: An Observational Study |
| Q38100875 | Liver or blood-stage arrest during malaria sporozoite immunization: the later the better? |
| Q34260189 | Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNγ responses of hepatic CD8+ memory T cells |
| Q41932967 | Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study |
| Q40783005 | MRP1 mediates folate transport and antifolate sensitivity in Plasmodium falciparum |
| Q33243034 | Malaria in Wanokaka and Loli sub-districts, West Sumba District, East Nusa Tenggara Province, Indonesia. |
| Q34730756 | Malaria infected mosquitoes express enhanced attraction to human odor |
| Q44168825 | Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial |
| Q44169388 | Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production |
| Q36785468 | Malaria transmission-blocking vaccines: the bonus of effective malaria control |
| Q34563555 | Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization |
| Q47965455 | Memory-like IFN-γ response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum |
| Q46062501 | Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection |
| Q54217209 | Modeling the impact of Plasmodium falciparum sexual stage immunity on the composition and dynamics of the human infectious reservoir for malaria in natural settings. |
| Q47096821 | Modelling mosquito infection at natural parasite densities identifies drugs targeting EF2, PI4K or ATP4 as key candidates for interrupting malaria transmission |
| Q44167789 | Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum |
| Q40042826 | Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial |
| Q56379066 | Mosquito Infectivity and Parasitemia after Controlled Human Malaria Infection |
| Q37173948 | Multidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoites |
| Q36547334 | NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections |
| Q43270221 | Neuroschistosomiasis; an unexpected finding in a Dutch woman |
| Q42121275 | New approach for high-throughput screening of drug activity on Plasmodium liver stages |
| Q41945030 | No hearing loss associated with the use of artemether-lumefantrine to treat experimental human malaria |
| Q40484106 | Novel pantothenate derivatives for anti-malarial chemotherapy |
| Q38964786 | Odours of Plasmodium falciparum-infected participants influence mosquito-host interactions |
| Q48001081 | On the way to eradicating malaria |
| Q46808212 | Persistence of full-length caspase-12 and its relation to malaria in West and Central African populations |
| Q35149404 | PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs |
| Q30043157 | Pfs47, paralog of the male fertility factor Pfs48/45, is a female specific surface protein in Plasmodium falciparum |
| Q33434412 | Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. |
| Q35095652 | Phenotyping clinical resistance to chloroquine in Plasmodium vivax in northeastern Papua, Indonesia |
| Q55362585 | Plant-produced transmission blocking Plasmodium falciparum Pfs25 subunit and VLP based vaccine candidates. |
| Q34507085 | Plasmodium berghei Δp52&p36 parasites develop independent of a parasitophorous vacuole membrane in Huh-7 liver cells |
| Q35947450 | Plasmodium falciparum Infection of Human Volunteers Activates Monocytes and CD16+ Dendritic Cells and Induces Upregulation of CD16 and CD1c Expression |
| Q39257141 | Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana |
| Q24798247 | Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya |
| Q44400436 | Plasmodium falciparum infection causes proinflammatory priming of human TLR responses |
| Q44166267 | Plasmodium liver load following parenteral sporozoite administration in rodents |
| Q52880874 | Plasmodium-associated changes in human odor attract mosquitoes. |
| Q59807801 | Pre-clinical evaluation of a -based whole-sporozoite malaria vaccine candidate |
| Q55283778 | Predicting the likelihood and intensity of mosquito infection from sex specific Plasmodium falciparum gametocyte density. |
| Q37361903 | Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines |
| Q42643524 | Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates |
| Q36835495 | Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity |
| Q35094826 | Protection of Malian children from clinical malaria is associated with recognition of multiple antigens |
| Q39687139 | Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites |
| Q40067174 | Protective immunity differs between routes of administration of attenuated malaria parasites independent of parasite liver load. |
| Q33381649 | Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity |
| Q33235842 | Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia |
| Q43946800 | Reduction and enhancement of Plasmodium falciparum transmission by endemic human sera |
| Q28476396 | Removal of heterologous sequences from Plasmodium falciparum mutants using FLPe-recombinase |
| Q42127740 | Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence |
| Q39051423 | Responses to malarial antigens are altered in helminth-infected children |
| Q36644534 | Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial |
| Q38866063 | Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity |
| Q34657110 | Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection |
| Q33507449 | Seasonal distribution of anti-malarial drug resistance alleles on the island of Sumba, Indonesia |
| Q43932462 | Seasonal patterns of Plasmodium falciparum gametocyte prevalence and density in a rural population of Burkina Faso |
| Q41912660 | Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection |
| Q36132026 | Spatial Patterns of Plasmodium falciparum Clinical Incidence, Asymptomatic Parasite Carriage and Anopheles Density in Two Villages in Mali |
| Q33960093 | Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum |
| Q28544964 | Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial |
| Q57154118 | Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody |
| Q58115505 | Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45 |
| Q39320276 | Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulation |
| Q35314263 | Studying the effect of chloroquine on sporozoite-induced protection and immune responses in Plasmodium berghei malaria |
| Q43736591 | Submicroscopic Plasmodium falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania |
| Q28474692 | Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya |
| Q27974482 | Targeting Plasmodium PI(4)K to eliminate malaria |
| Q44161485 | Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction |
| Q28551321 | The Impact of Hotspot-Targeted Interventions on Malaria Transmission in Rachuonyo South District in the Western Kenyan Highlands: A Cluster-Randomized Controlled Trial |
| Q57296267 | The Plasmodium falciparum male gametocyte protein P230p, a paralog of P230, is vital for ookinete formation and mosquito transmission |
| Q47909162 | The Plasmodium falciparum var gene transcription strategy at the onset of blood stage infection in a human volunteer |
| Q36247418 | The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection |
| Q92413853 | The XN-30 hematology analyzer for rapid sensitive detection of malaria: a diagnostic accuracy study |
| Q55353878 | The complement system contributes to functional antibody-mediated responses induced by immunization with Plasmodium falciparum malaria sporozoites. |
| Q47832907 | The dog that did not bark: malaria vaccines without antibodies |
| Q36538665 | The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion |
| Q47942237 | The first malaria vaccine: a significant milestone |
| Q27973784 | The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system |
| Q26315349 | The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays |
| Q33553363 | Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility |
| Q33375855 | Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria |
| Q33392346 | Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy |
| Q37163165 | Transcriptomic evidence for modulation of host inflammatory responses during febrile Plasmodium falciparum malaria |
| Q39690044 | Transmission of Plasmodium falciparum in urban Yaoundé, Cameroon, is seasonal and age-dependent |
| Q30042977 | Two Plasmodium 6-Cys family-related proteins have distinct and critical roles in liver-stage development |
| Q27973456 | Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes |
| Q36564961 | Variation in susceptibility of African Plasmodium falciparum malaria parasites to TEP1 mediated killing in Anopheles gambiae mosquitoes |
| Q27335248 | Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging |
| Q39399082 | Vital and dispensable roles of Plasmodium multidrug resistance transporters during blood- and mosquito-stage development |
| Q92642716 | Whole-blood transcriptomic signatures induced during immunization by chloroquine prophylaxis and Plasmodium falciparum sporozoites |
Search more.